Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 062833
Company: NASKA
Company: NASKA
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE | BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE | 400 UNITS/GM;EQ 3.5MG BASE/GM;5,000 UNITS/GM | OINTMENT;TOPICAL | Discontinued | None | No | No |